The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
EliteSynth Laboratories
Navi Mumbai, India
11-50 Employees
2019
Elitesynth is a custom synthesis and analytical laboratory. Established in 2019 and we are based in India. To be a leading service provider in India and a significant global player by providing innovative and affordable solutions. To provide quality and affordable services to the pharmaceutical industry under one roof and ensure total customer satisfaction.
Product
Atorvastatin
Ind-Swift Laboratories
Chandigarh, India
1001-5000 Employees
1995
We are today an integrated pharmaceutical organization with global footprints.We take pride in our constant efforts to contribute towards offering better health to the world. We are born to fly high and grow and we deliver the same with constant trust and support of our valuable customer base across the globe. Promoting wellness is a way of life with us. We have a knack of exceeding expectations through constant product improvisation. A quality par-excellence, delivering seamlessly is our hallmark. Adherence to established quality standards assures safety and efficiency of drug products. Twenty Years on, what has stayed in our organization’s inheritance is the same spirit of flying high with pride. Our current industrial position is achieved after years of research driven manufacturing of products that constantly meet global standards of quality.
Product
Atorvastatin Diamino
axapharm ag
Baar, Switzerland
11-50 Employees
2006
Seit der Gründung von axapharm haben sich über 700 Schweizer Apotheker und Drogisten als Aktionäre und Medikamenten-Fachhändler dem rein schweizerischen Unternehmen angeschlossen.
Product
Atorvastatin axapharm
GNH India Pharmaceuticals Limited
Mumbai, India
11-50 Employees
-
We are one of the Pioneers in Comparator drug supplies from India ! Our goal is to source, distribute and deliver pharmaceutical products to everyone who needs them most, and all without any of the unforeseen delays that you simply cannot afford. We are impressed by the efficiency and the high quality standard of your company. GNHIndia Pharmaceuticals has been representing India since since 2011. GNH India is a Global Pharmaceutical Distributor with over 203,000 products lines covering Original brands and True Generic. This summary is designed to provide you an overview and help you in managing the company’s finances. Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders. At GNH India, we take pride in being a leading pharmaceuticals distributor and believe nothing should stand in the way of what people truly need.
Product
Ramipril & Atorvastatin Tablets (Cardace)
dabeipackzettel
Hallstadt, Germany
1-10 Employees
2020
Wir glauben, dass frei zugängliche und vertrauenswürdige Informationen dabei helfen Therapien besser durchzuführen, schneller gesund zu werden oder zu bleiben. Dafür kombinieren wir Informationen aus unterschiedlichen Quellen, wie Medikamentendatenbanken oder direkt von den Herstellern.
Product
Atorvastatin AbZ 20mg Filmtabletten
Tcipatent Ltd
United Kingdom
1-10 Employees
2009
Product
Specific Report: Atorvastatin – Syntheses (130)
Midas Pharma
Ingelheim am Rhein, Germany
251-500 Employees
1988
Founded 35 years ago by economist Karl-Heinz Schleicher in Gau-Algesheim, Midas Pharma has since developed into an internationally active group of companies. Step by step, the company expanded its competences and founded subsidiaries in all important pharmaceutical markets worldwide. Today, Midas Pharma offers its customers and partners a wide range of products and services along the entire pharmaceutical value chain. Whether you are looking for a manufacturing partner, support in regulatory affairs or plan to expand your business network – Midas Pharma provides products, services and expertise across the full industry value chain. Present in all major pharmaceutical markets worldwide, we offer services to contribute to your success.
Product
Atorvastatin Calcium
Lannett Company
Philadelphia, United States
501-1000 Employees
1942
We are a US-based company, with our headquarters in Trevose, PA, and top-notch facilities for research and development, manufacturing, packaging, business, and distribution in two states including Pennsylvania, and Indiana. The Lannett team is made up of individuals who care deeply about what they do and doing their job well. For over 75 years, Lannett has been proudly providing high-quality, affordable generic pharmaceutical products to patients who depend on them. We manufacture over 100 unique pharmaceutical product families for a wide range of therapeutic areas, with many more in development. Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension. Our leadership is committed to quality, adherence to FDA standards, and compliance with regulatory requirements to ensure patient safety. Learn about how you can make a positive impact, with a career at Lannett. With extensive manufacturing and product development capabilities, we manufacture quality products for pharmaceutical wholesale distributors.
Product
Atorvastatin Calcium
CJA Medical
Southampton, United Kingdom
1-10 Employees
-
Product
Atorvastatin
Healthy Life
-
- Employees
1968
At Healthylife, we’re making good health even easier and more accessible. Healthylife was built alongside health experts to help ditch the complexity around health and make living healthier, easier.
Product
Generic Atorvastatin (40mg) 30 Tablets
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about your company results for Atorvastatin
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 1186 |
| Amount of suitable service providers | 940 |
| Average amount of employees | 51-100 |
| Oldest suiting company | 1948 |
| Youngest suiting company | 2016 |
20%
40%
60%
80%
Atorvastatin, a synthetic lipid-lowering agent, falls under the class of medications known as statins. It functions primarily by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in the production of cholesterol in the liver. This inhibition leads to a decrease in the liver's production of cholesterol, thereby reducing the total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides in the blood, while modestly increasing levels of high-density lipoprotein (HDL) cholesterol. Its efficacy in lowering LDL cholesterol makes it a cornerstone in the management of dyslipidemia—a condition characterized by abnormal lipid levels in the blood. Atorvastatin's role extends beyond lipid regulation; it also offers benefits in reducing the risk of heart attack, stroke, and other complications related to cardiovascular disease in individuals at high risk. This medication's impact within its field is profound, as it not only addresses a key modifiable risk factor for cardiovascular disease but also contributes to the broader strategy of cardiovascular risk management. The widespread use of atorvastatin and its significant role in preventive healthcare underscores its importance in both the clinical and public health domains, making it one of the most prescribed medications worldwide.
1. Reduces LDL Cholesterol
Atorvastatin is highly effective in lowering low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol. This reduction significantly decreases the risk of heart disease and stroke, offering a substantial advantage over some alternative cholesterol-lowering medications that might not be as potent in reducing LDL levels.
2. Improves Cardiac Health
Clinical studies have shown that Atorvastatin not only lowers bad cholesterol but also has a beneficial effect on overall cardiac health. It can help stabilize plaque in the arteries, reducing the risk of heart attacks. This aspect of Atorvastatin is particularly important for patients with existing heart conditions or a high risk of cardiovascular disease.
3. Flexibility in Dosage
Another key benefit of Atorvastatin is the flexibility in dosing that it offers. It is available in a range of doses, allowing healthcare providers to tailor the treatment to the specific needs and responses of the patient. This adaptability can lead to more personalized care and potentially better outcomes compared to some alternatives that have more limited dosing options.
4. Proven Track Record
Atorvastatin has been extensively studied and has a long track record of safety and effectiveness. Its widespread use and the wealth of clinical data supporting its benefits give both doctors and patients confidence in its use as a first-line treatment for high cholesterol and related conditions.
1. Compliance with Regulatory Standards
Ensure the supplier adheres to international pharmaceutical regulations and quality standards like GMP (Good Manufacturing Practice) and FDA (Food and Drug Administration) approvals. This compliance is crucial for ensuring the safety and efficacy of Atorvastatin.
2. Raw Material Sourcing
Investigate the origin and quality of raw materials used in Atorvastatin production. High-quality, pure ingredients contribute significantly to the final product's effectiveness.
3. Production Capabilities
Confirm the supplier's production capacity to ensure they can meet your demand without compromising quality. This includes assessing their technology, equipment, and scalability.
4. Supply Chain Reliability
Evaluate the robustness of the supplier's supply chain, focusing on their ability to deliver consistently and on time, which is vital for maintaining uninterrupted supply.
5. Cost-effectiveness
While quality should not be compromised, comparing costs among suppliers offering equivalent standards can help in making an economical choice without sacrificing quality.
6. Customer Service and Support
Consider the level of customer service, including responsiveness, after-sales support, and technical assistance. Good customer service can significantly ease the procurement process and future communications.
Atorvastatin, widely known for its cholesterol-lowering properties, finds its application across several B2B sectors, notably in the pharmaceutical and healthcare industries. In the pharmaceutical domain, companies extensively use Atorvastatin as a key ingredient in the production of statin drugs. These medications are pivotal in managing and preventing heart disease by reducing cholesterol levels in the blood, showcasing the compound's critical role in public health initiatives and medication manufacturing. Beyond its primary medical application, Atorvastatin also plays a significant role in research and development within biotechnology firms. Researchers leverage this compound to study its effects on various cardiovascular diseases and explore potential new therapeutic uses. This research is vital for the development of innovative treatments, highlighting Atorvastatin's contribution to advancing medical science and healthcare solutions. Furthermore, the insurance industry benefits indirectly from the widespread use of Atorvastatin. By incorporating this medication into treatment plans, insurers can potentially reduce the long-term costs associated with cardiovascular diseases. This preventive approach aids in minimizing the financial impact on both the insurers and the insured, underscoring Atorvastatin's value in promoting health and financial stability. In summary, Atorvastatin serves as a cornerstone in the pharmaceutical production of cholesterol-lowering drugs, fuels research in biotechnology for new therapies, and assists the insurance sector in managing healthcare costs. Its multifaceted utility across these B2B industries underscores its importance in the broader health and business ecosystems.
Atorvastatin, commonly known by its brand name Lipitor, is a widely used statin medication for lowering blood cholesterol, which has reached the highest Technology Readiness Level (TRL) of 9. This TRL indicates that Atorvastatin has been fully commercialized and is utilized extensively in real-world settings. The progression to this TRL is grounded in extensive clinical trials and research that have conclusively demonstrated its efficacy in reducing low-density lipoprotein (LDL) cholesterol, mitigating the risk of heart disease, and being beneficial for a range of cardiovascular conditions. Over the years, Atorvastatin has undergone rigorous Phase I, II, and III clinical trials, which have not only proven its effectiveness but also established a comprehensive profile of its safety for human use. Post-marketing surveillance has further solidified its standing by monitoring its performance and safety in a broader population over time. The technical foundation for Atorvastatin's high TRL is its well-understood mechanism of action, which involves inhibiting HMG-CoA reductase, a key enzyme in the cholesterol biosynthesis pathway in the liver, leading to a significant reduction in intrahepatic cholesterol levels. This precise targeting and the subsequent detailed understanding of its pharmacokinetics and pharmacodynamics underpin its classification at the pinnacle of the TRL scale.
In the Short-Term, advancements in the formulation of Atorvastatin are anticipated to focus on increasing its bioavailability and reducing side effects. Innovations may include the development of nanoparticle-based delivery systems, which aim to enhance the absorption of the drug, making it more efficient at lower doses. This phase is likely to see the introduction of more sophisticated compounding techniques that could minimize common side effects such as muscle pain and fatigue, improving patient compliance and treatment outcomes. Moving into the Mid-Term phase, research is expected to pivot towards the integration of Atorvastatin with digital health technologies. This could involve the use of smart pills equipped with microsensors to monitor the drug's efficacy in real-time, providing personalized data to healthcare providers. Such technology would not only optimize dosage regimens but also enable early detection of adverse reactions. Additionally, this period may witness the exploration of Atorvastatin's potential in treating conditions beyond cholesterol management, fueled by its anti-inflammatory properties. In the Long-Term, the focus will likely shift towards gene-editing technologies and their application in conjunction with Atorvastatin therapy. Advances in CRISPR and other gene-editing tools could pave the way for targeted modifications to enhance the body's natural cholesterol processing abilities. This cutting-edge approach aims to offer a more permanent solution to cholesterol management, potentially reducing the reliance on daily medication and revolutionizing cardiovascular disease treatment.
Some interesting questions that has been asked about the results you have just received for Atorvastatin
What are related technologies to Atorvastatin?
Based on our calculations related technologies to Atorvastatin are Aromatics, Desiccants, Refrigerants, Resins, Green Chemistry
Which industries are mostly working on Atorvastatin?
The most represented industries which are working in Atorvastatin are Pharmaceuticals, Other, Healthcare, Biotechnology, Retail
How does ensun find these Atorvastatin Suppliers?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
